ERBB2 and breast carcinoma: This analysis revealed a statistically significant increase in the CD3+ population within the stromal area of NSCLC as compared to BCa (Fig 5B), which reflects the low level of immune infiltration typically observed in ER+, PR+, and/or HER2+ breast cancer [23–25].